drugset / Trial / NCT00455117

Effect of Parecoxib on Post-craniotomy Pain

NCT00455117

Phase 4 Completed 130 enrolled Melbourne Health
RandomizedParallel-groupDouble-blindTreatment

Summary

Aim of this trial: To investigate whether post-craniotomy analgesia with (i) intravenous (IV) parecoxib plus intravenous paracetamol is superior to (ii) intravenous paracetamol alone. Study Hypothesis: Post-operative analgesia with intravenous parecoxib in combination with intravenous paracetamol will be superior to intravenous paracetamol alone.

Timeline

Start
2006-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Parecoxib Small molecule 40 mg Intravenous

Indications

No indication recorded.